Logo image of MIR

MIRION TECHNOLOGIES INC (MIR) Stock Fundamental Analysis

NYSE:MIR - US60471A1016 - Common Stock

20.61 USD
+0.11 (+0.54%)
Last: 9/2/2025, 5:05:01 PM
20.64 USD
+0.03 (+0.15%)
After Hours: 9/2/2025, 5:05:01 PM
Fundamental Rating

3

Overall MIR gets a fundamental rating of 3 out of 10. We evaluated MIR against 125 industry peers in the Electronic Equipment, Instruments & Components industry. MIR has only an average score on both its financial health and profitability. While showing a medium growth rate, MIR is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

In the past year MIR was profitable.
In the past year MIR had a positive cash flow from operations.
In the past 5 years MIR always reported negative net income.
Each year in the past 5 years MIR had a positive operating cash flow.
MIR Yearly Net Income VS EBIT VS OCF VS FCFMIR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -100M -200M

1.2 Ratios

MIR has a Return On Assets (0.37%) which is in line with its industry peers.
The Return On Equity of MIR (0.68%) is comparable to the rest of the industry.
With a Return On Invested Capital value of 1.50%, MIR perfoms like the industry average, outperforming 53.60% of the companies in the same industry.
Industry RankSector Rank
ROA 0.37%
ROE 0.68%
ROIC 1.5%
ROA(3y)-5.01%
ROA(5y)-6.97%
ROE(3y)-9.58%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MIR Yearly ROA, ROE, ROICMIR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 10 -10

1.3 Margins

MIR has a Profit Margin (1.13%) which is comparable to the rest of the industry.
MIR has a Operating Margin of 5.27%. This is in the better half of the industry: MIR outperforms 66.40% of its industry peers.
In the last couple of years the Operating Margin of MIR has declined.
MIR has a better Gross Margin (46.70%) than 79.20% of its industry peers.
MIR's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 5.27%
PM (TTM) 1.13%
GM 46.7%
OM growth 3Y18.9%
OM growth 5Y-14%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.09%
GM growth 5Y1.66%
MIR Yearly Profit, Operating, Gross MarginsMIR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 -20 40

More info and screens

4

2. Health

2.1 Basic Checks

MIR has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for MIR has been increased compared to 1 year ago.
MIR has a worse debt/assets ratio than last year.
MIR Yearly Shares OutstandingMIR Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 50M 100M 150M 200M
MIR Yearly Total Debt VS Total AssetsMIR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

An Altman-Z score of 2.55 indicates that MIR is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of MIR (2.55) is worse than 62.40% of its industry peers.
MIR has a debt to FCF ratio of 9.95. This is a negative value and a sign of low solvency as MIR would need 9.95 years to pay back of all of its debts.
The Debt to FCF ratio of MIR (9.95) is comparable to the rest of the industry.
A Debt/Equity ratio of 0.57 indicates that MIR is somewhat dependend on debt financing.
MIR has a worse Debt to Equity ratio (0.57) than 72.80% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF 9.95
Altman-Z 2.55
ROIC/WACC0.16
WACC9.51%
MIR Yearly LT Debt VS Equity VS FCFMIR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 500M -500M 1B 1.5B 2B

2.3 Liquidity

A Current Ratio of 2.54 indicates that MIR has no problem at all paying its short term obligations.
MIR has a Current ratio of 2.54. This is comparable to the rest of the industry: MIR outperforms 56.80% of its industry peers.
MIR has a Quick Ratio of 2.01. This indicates that MIR is financially healthy and has no problem in meeting its short term obligations.
MIR's Quick ratio of 2.01 is fine compared to the rest of the industry. MIR outperforms 60.80% of its industry peers.
Industry RankSector Rank
Current Ratio 2.54
Quick Ratio 2.01
MIR Yearly Current Assets VS Current LiabilitesMIR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 27.78% over the past year.
MIR shows a small growth in Revenue. In the last year, the Revenue has grown by 7.88%.
MIR shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 14.36% yearly.
EPS 1Y (TTM)27.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%10%
Revenue 1Y (TTM)7.88%
Revenue growth 3Y12.07%
Revenue growth 5Y14.36%
Sales Q2Q%7.63%

3.2 Future

Based on estimates for the next years, MIR will show a quite strong growth in Earnings Per Share. The EPS will grow by 18.98% on average per year.
The Revenue is expected to grow by 7.92% on average over the next years.
EPS Next Y19.62%
EPS Next 2Y18.44%
EPS Next 3Y18.98%
EPS Next 5YN/A
Revenue Next Year8.56%
Revenue Next 2Y8.26%
Revenue Next 3Y7.92%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
MIR Yearly Revenue VS EstimatesMIR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
MIR Yearly EPS VS EstimatesMIR Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 44.80, the valuation of MIR can be described as expensive.
MIR's Price/Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Earnings ratio of 27.13, MIR is valued quite expensively.
MIR is valuated quite expensively with a Price/Forward Earnings ratio of 35.83.
MIR's Price/Forward Earnings ratio is in line with the industry average.
When comparing the Price/Forward Earnings ratio of MIR to the average of the S&P500 Index (22.76), we can say MIR is valued expensively.
Industry RankSector Rank
PE 44.8
Fwd PE 35.83
MIR Price Earnings VS Forward Price EarningsMIR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as MIR.
The rest of the industry has a similar Price/Free Cash Flow ratio as MIR.
Industry RankSector Rank
P/FCF 57.61
EV/EBITDA 28.57
MIR Per share dataMIR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as MIR's earnings are expected to grow with 18.98% in the coming years.
PEG (NY)2.28
PEG (5Y)N/A
EPS Next 2Y18.44%
EPS Next 3Y18.98%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MIR!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MIRION TECHNOLOGIES INC

NYSE:MIR (9/2/2025, 5:05:01 PM)

After market: 20.64 +0.03 (+0.15%)

20.61

+0.11 (+0.54%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)07-31 2025-07-31/amc
Earnings (Next)10-27 2025-10-27
Inst Owners84.58%
Inst Owner Change8.15%
Ins Owners4.41%
Ins Owner Change-2.13%
Market Cap4.82B
Analysts84.44
Price Target21.83 (5.92%)
Short Float %7.2%
Short Ratio5.26
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)17.49%
Min EPS beat(2)8.05%
Max EPS beat(2)26.94%
EPS beat(4)3
Avg EPS beat(4)9.22%
Min EPS beat(4)-11.99%
Max EPS beat(4)26.94%
EPS beat(8)6
Avg EPS beat(8)9.28%
EPS beat(12)8
Avg EPS beat(12)6.21%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.86%
Min Revenue beat(2)-0.35%
Max Revenue beat(2)2.07%
Revenue beat(4)3
Avg Revenue beat(4)1.25%
Min Revenue beat(4)-0.35%
Max Revenue beat(4)2.76%
Revenue beat(8)5
Avg Revenue beat(8)1.52%
Revenue beat(12)8
Avg Revenue beat(12)1.82%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)3.88%
PT rev (3m)13.83%
EPS NQ rev (1m)-6.54%
EPS NQ rev (3m)-4.53%
EPS NY rev (1m)1.55%
EPS NY rev (3m)1.11%
Revenue NQ rev (1m)0.7%
Revenue NQ rev (3m)2.32%
Revenue NY rev (1m)1.6%
Revenue NY rev (3m)2.07%
Valuation
Industry RankSector Rank
PE 44.8
Fwd PE 35.83
P/S 5.44
P/FCF 57.61
P/OCF 38.3
P/B 3.3
P/tB N/A
EV/EBITDA 28.57
EPS(TTM)0.46
EY2.23%
EPS(NY)0.58
Fwd EY2.79%
FCF(TTM)0.36
FCFY1.74%
OCF(TTM)0.54
OCFY2.61%
SpS3.79
BVpS6.25
TBVpS-1.65
PEG (NY)2.28
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.37%
ROE 0.68%
ROCE 1.89%
ROIC 1.5%
ROICexc 1.68%
ROICexgc 10.58%
OM 5.27%
PM (TTM) 1.13%
GM 46.7%
FCFM 9.45%
ROA(3y)-5.01%
ROA(5y)-6.97%
ROE(3y)-9.58%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y18.71%
ROICexcg growth 5YN/A
ROICexc growth 3Y10.74%
ROICexc growth 5YN/A
OM growth 3Y18.9%
OM growth 5Y-14%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.09%
GM growth 5Y1.66%
F-Score8
Asset Turnover0.32
Health
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF 9.95
Debt/EBITDA 4.44
Cap/Depr 29.99%
Cap/Sales 4.76%
Interest Coverage 0.96
Cash Conversion 67.18%
Profit Quality 837%
Current Ratio 2.54
Quick Ratio 2.01
Altman-Z 2.55
F-Score8
WACC9.51%
ROIC/WACC0.16
Cap/Depr(3y)24.94%
Cap/Depr(5y)26.34%
Cap/Sales(3y)5.02%
Cap/Sales(5y)4.6%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)27.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%10%
EPS Next Y19.62%
EPS Next 2Y18.44%
EPS Next 3Y18.98%
EPS Next 5YN/A
Revenue 1Y (TTM)7.88%
Revenue growth 3Y12.07%
Revenue growth 5Y14.36%
Sales Q2Q%7.63%
Revenue Next Year8.56%
Revenue Next 2Y8.26%
Revenue Next 3Y7.92%
Revenue Next 5YN/A
EBIT growth 1Y1768%
EBIT growth 3Y33.25%
EBIT growth 5Y-1.65%
EBIT Next Year481.98%
EBIT Next 3Y96.8%
EBIT Next 5YN/A
FCF growth 1Y542.86%
FCF growth 3Y18.28%
FCF growth 5YN/A
OCF growth 1Y696.84%
OCF growth 3Y22.74%
OCF growth 5Y46.47%